Dopamine dysfunction in borderline personality disorder: a hypothesis (Q35708862)

9 August 2017

1 reference

title

Dopamine dysfunction in borderline personality disorder: a hypothesis (English)

1 reference

borderline personality disorder

9 August 2017

main subject

0 references

author name string

Robert O Friedel

series ordinal

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

9 August 2017

published in

Neuropsychopharmacology

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

1029-1039

1 reference

The primate amygdala and the neurobiology of social behavior: implications for understanding social anxiety

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Emotion, decision making and the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Operant Reward Learning in Aplysia: Neuronal Correlates and Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Impulsive choice induced in rats by lesions of the nucleus accumbens core.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Toward a Biology of Personality and Emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Anxiety and affective style: role of prefrontal cortex and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Dysfunction in the neural circuitry of emotion regulation--a possible prelude to violence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Brain glucose metabolism in borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Effects of medial prefrontal cortical injections of GABA receptor agonists and antagonists on the local and nucleus accumbens dopamine responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Anger in healthy men: a PET study using script-driven imagery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

The effects of stress on central dopaminergic neurons: possible clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Regional and cellular fractionation of working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Positron-emission tomography and personality disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Neurotransmitter dysfunction in patients with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Stimulation of protein kinase a activity in the rat amygdala enhances reward-related learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Positron emission tomography in female patients with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Extended amygdala and emotional salience: a PET activation study of positive and negative affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

A brain MRI study in subjects with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Frontal-subcortical circuits: the anatomic basis of executive, social and motivated behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Effect of haloperidol on measures of craving and impaired control in alcoholic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Borderline personality disorder. Neuropsychological testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

The biology of impulsivity and suicidality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Neuroscience. A bite to remember

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

A voxel-based morphometric MRI study in female patients with borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Neural correlates of memories of abandonment in women with and without borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

The amphetamine challenge test in patients with borderline disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Amphetamine response in borderline patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Role for cingulate motor area cells in voluntary movement selection based on reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Cognitive and brain function in schizotypal personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Borderline personality disorder. Overview of biologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

The borderline diagnosis II: biology, genetics, and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Efficacy of phenelzine and haloperidol in borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognitive Performance in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Diverse psychotomimetics act through a common signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

DARPP-32 mediates serotonergic neurotransmission in the forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Differential diagnosis of personality disorders by the seven-factor model of temperament and character.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Neuropsychiatric symptoms from the temporolimbic lobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Addiction, a Disease of Compulsion and Drive: Involvement of the Orbitofrontal Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Dopamine D2L receptor- and age-related reduction in offensive aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Relation among dopamine D(2) receptor binding, obesity and personality in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Axis I Comorbidity of Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Clozapine treatment of borderline patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

The neurobiology of dopamine signaling

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Are placebo controls necessary to test new antidepressants and anxiolytics?

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Dysphoria associated with methylphenidate infusion in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Pharmacological prevention of suicidal behaviour

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

A fenfluramine-activated FDG-PET study of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Risperidone in Comorbid Borderline Personality Disorder and Dysthymia

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300424

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300424

1 reference

release_y52nqk6jbzgnfbgtvp7ijhglg4

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y52nqk6jbzgnfbgtvp7ijhglg4

24 November 2022

mapped directly with Wikidata item

1 reference